Abbott Laboratories Total Assets 2006-2019 | ABT

Abbott Laboratories total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Abbott Laboratories total assets for the quarter ending March 31, 2019 were $67.610B, a 4.65% decline year-over-year.
  • Abbott Laboratories total assets for 2018 were $67.173B, a 11.9% decline from 2017.
  • Abbott Laboratories total assets for 2017 were $76.25B, a 44.78% increase from 2016.
  • Abbott Laboratories total assets for 2016 were $52.666B, a 27.68% increase from 2015.
Abbott Laboratories Annual Total Assets
(Millions of US $)
2018 $67,173
2017 $76,250
2016 $52,666
2015 $41,247
2014 $41,207
2013 $42,953
2012 $67,235
2011 $60,277
2010 $60,574
2009 $52,582
2008 $42,419
2007 $39,714
2006 $36,178
2005 $29,141
Abbott Laboratories Quarterly Total Assets
(Millions of US $)
Q1 2019 $67,610
Q4 2018 $67,173
Q3 2018 $71,637
Q2 2018 $68,415
Q1 2018 $70,908
Q4 2017 $76,250
Q3 2017 $72,248
Q2 2017 $71,151
Q1 2017 $70,887
Q4 2016 $52,666
Q3 2016 $39,497
Q2 2016 $39,831
Q1 2016 $39,637
Q4 2015 $41,247
Q3 2015 $41,725
Q2 2015 $44,125
Q1 2015 $43,095
Q4 2014 $41,207
Q3 2014 $42,514
Q2 2014 $41,475
Q1 2014 $41,662
Q4 2013 $42,953
Q3 2013 $44,132
Q2 2013 $42,903
Q1 2013 $42,687
Q4 2012 $67,235
Q3 2012 $63,258
Q2 2012 $61,860
Q1 2012 $62,416
Q4 2011 $60,277
Q3 2011 $59,628
Q2 2011 $62,004
Q1 2011 $61,651
Q4 2010 $60,574
Q3 2010 $57,374
Q2 2010 $53,381
Q1 2010 $53,359
Q4 2009 $52,582
Q3 2009 $49,847
Q2 2009 $47,630
Q1 2009 $45,438
Q4 2008 $42,419
Q3 2008 $41,753
Q2 2008 $44,074
Q1 2008 $41,178
Q4 2007 $39,714
Q3 2007 $37,622
Q2 2007 $37,153
Q1 2007 $36,286
Q4 2006 $36,178
Q3 2006 $33,300
Q2 2006 $34,061
Q1 2006 $28,532
Q4 2005 $29,141
Q3 2005 $28,831
Q2 2005 $27,817
Q1 2005 $28,857
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $151.296B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $135.350B 19.33
Stryker (SYK) United States $77.587B 27.69
Boston Scientific (BSX) United States $58.741B 28.16
Baxter (BAX) United States $42.165B 26.58
EssilorLuxottica Societe Anonyme (ESLOY) France $28.527B 0.00
Coloplast (CLPBY) Denmark $25.661B 40.97
Lonza Group Ag (LZAGY) Switzerland $25.304B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.194B 16.19
Terumo (TRUMY) Japan $22.193B 25.52
Smith & Nephew SNATS (SNN) United Kingdom $19.113B 0.00
ResMed (RMD) United States $17.749B 33.91
Canopy Growth (CGC) Canada $12.652B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.194B 48.74
Aurora Cannabis (ACB) Canada $7.514B 74.10
William Demant Holdings (WILYY) Denmark $7.411B 0.00
Insulet (PODD) United States $7.236B 527.17
Hill-Rom Holdings (HRC) United States $7.121B 21.59
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.254B 51.05
ICU Medical (ICUI) United States $5.122B 30.57
GW Pharmaceuticals (GWPH) United Kingdom $4.916B 0.00
Neogen (NEOG) United States $3.373B 54.85
NuVasive (NUVA) United States $2.987B 24.39
Hutchison China MediTech (HCM) China $2.906B 0.00
Agios Pharmaceuticals (AGIO) United States $2.848B 0.00
National Vision Holdings (EYE) United States $2.479B 52.82
Quidel (QDEL) United States $2.261B 23.46
Aphria (APHA) $1.646B 0.00
Cardiovascular Systems (CSII) United States $1.530B 878.80
Phibro Animal Health (PAHC) United States $1.212B 18.16
AtriCure (ATRC) United States $1.196B 0.00
VAREX IMAGING (VREX) United States $1.177B 24.98
NanoString Technologies (NSTG) United States $1.065B 0.00
Lantheus Holdings (LNTH) United States $1.052B 27.95
PetIQ (PETQ) United States $1.008B 24.49
Quanterix (QTRX) United States $0.783B 0.00
Cerus (CERS) United States $0.769B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Omeros (OMER) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.740B 0.00
TG Therapeutics (TGTX) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.591B 28.62
Surmodics (SRDX) United States $0.533B 77.45
OraSure Technologies (OSUR) United States $0.522B 24.06
Meridian Bioscience (VIVO) United States $0.489B 14.96
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.51
BioLife Solutions (BLFS) United States $0.313B 97.88
Zynex (ZYXI) United States $0.242B 24.90
Cytosorbents (CTSO) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.224B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Owens & Minor (OMI) United States $0.178B 3.77
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Female Health (VERU) United States $0.143B 0.00
Fonar (FONR) United States $0.141B 7.40
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.58
MRI INTERVENTNS (MRIC) United States $0.053B 0.00